Board of Directors
Stanley Lapidus, President, CEO and Founder
Stan is an experienced life-science entrepreneur and inventor with over 30 issued US patents. He founded and led Cytyc, EXACT Sciences and Helicos BioSciences (NASDAQ: CYTC, EXAS, HLCS), and holds academic appointments at Tufts and MIT. Since 2002, Stan has served as a trustee of Cooper Union, his alma mater.
Robert Carpenter is Chairman of Hydra Biosciences Inc., a company he helped found which is conducting research in a new class of ion channels. Previously, he served as Executive Vice President of Genzyme Corporation, and founded two life sciences companies, Integrated Genetics and GelTex Pharmaceuticals, that went public and were acquired by Genzyme. He was a Director of Genzyme from 1994 to 2010 and held the position of Lead Director from 2008 to 2010. In 2002, Mr. Carpenter also helped spin out a subsidiary of Genzyme called Peptimmune Inc., of which he was Chairman of the Board until 2007. He currently serves as a director of Moderna, Good Start Genetics, SynapDx and Immuneering Inc.. He holds a BA from the United States Military Academy at West Point, an MS in Computer Science from Stanford University, and an MBA from Harvard University.
Andrew Conrad, PhD, Google [x]
Andy Conrad oversees two major projects at Google [x], Google Inc's "moonshot factory" and provides overall guidance on various scientific and hardware products and research. Previously he was Chief Scientific Officer of Laboratory Corporation of America (LapCorp). He is the co-founder of the National Genetics Institute where he served as Chief Scientific Officer. Andy also founded the California Health and Longevity Institute (CHLI) and serves as the Chief Scientific Advisor of the North Carolina Research Campus (NCRC), an academic collaboration between Duke University, University of North Carolina and North Carolina State University. Andy holds a Ph.D in Cell Biology from the University of California Los Angeles.
Kevin Hrusovsky served as President of PerkinElmer Life Sciences from 2011 to 2013, following the acquisition of Caliper Life Sciences, where he served as CEO and President from 2003 to 2011. Kevin oversaw a tenfold increase in Caliper’s market value during the three years prior to the sale to PerkinElmer for $650m. Previously, Kevin was CEO and President of Zymark Corporation from 1996 to 2003, and held senior positions at FMC Corporation and E.I. duPont de Nemours. His current and past board seats include 908 Devices, SynapDx, Solect, Caliper, SeraCare, Xenogen, Alliant Medical, Society of Lab Automation, Center of Biomedical Engineering at Brown University and the Strategy Committee of Boston Children's Hospital. Kevin holds a BS in Mechanical Engineering from the Ohio State University and an MBA from Ohio University.
Thomas Mac Mahon
Tom was Chairman, President and Chief Executive Officer of Laboratory Corporation of America (LabCorp) from 1997 until his retirement in December, 2006. Previously, he was President of Roche Diagnostics Group from 1988-1996. He currently serves on the Boards of LabCorp, Express Scripts, Inc. and PharMerica Corp. He also serves on the Boards of St. Peter's College and Elon University. He has an undergraduate degree from St. Peter's College (1968) and an MBA from Fairleigh Dickinson (1972).
Carmichael Roberts, PhD, North Bridge Venture Partners
Carmichael is an entrepreneur-investor who helps founders build successful companies from inception. Carmichael’s primary industry areas include medical, energy and electronics. Carmichael is co-founder and Chairman of Diagnostics For All, Inc., a non-profit organization that makes low cost diagnostics for poor and rural populations in developing nations. He is on the Board of Trustees of Duke University and the Berklee College of Music. Carmichael serves formally as an advisor to the United States Secretary of Energy. He has received his B.S. and Ph.D. in organic chemistry from Duke University and was a National Science Foundation Fellow at Harvard University. Carmichael earned his MBA from the MIT Sloan School of Management.
Hemant Taneja, General Catalyst Partners, Managing Director
Hemant invests in healthcare, clean energy and internet communications. He is co-founder and Chairman of Sunborne Energy. Hemant co-founded Isovia, later acquired by JP Mobile (MOT). He co-founded and chairs the New England Clean Energy Council. He holds an M.S. in Operations Research, a BS and MEng in Electrical Engineering & Computer Science, and a BS in Mathematics, Biology & Biomedical Engineering from MIT.
Eli Casdin, Casdin Capital
Eli Casdin is the founder and managing member of Casdin Capital, a Life Science investment firm. Prior to founding Casdin Capital, Eli was a senior research analyst at AllianceBernstein advising portfolio teams on life science and biotechnology investments. Eli joined AllianceBernstein in 2007 from Cooper Hill Partners where he began his career in 2003 as a research analyst. Eli has an MBA from Columbia Business School and BS from Columbia University.
Bill Geary, Foundation Medical Partners, General Partner
Bill has been in healthcare venture capital investing for more than 20 years. Representative investments include: Connance, eBenX, Humedica, Pharmetrics, and Valence Health. Prior to Foundation Medical Partners, he was a Partner at North Bridge Venture Partners, where he worked since the firm’s founding in 1994. Bill holds an undergraduate degree from Boston College and has served his alma mater in a variety of roles including Chair of the Board of Trustees. He also serves on the Advisory Board of the Children’s Hospital Boston Technology Fund, the Center For Connected Health at Boston's Partners HealthCare System, and on the Business Advisory Board of the Joslin Diabetes Center.
Krishna Yeshwant, MD, Google Ventures
Krishna is a physician, programmer, and entrepreneur who has been working with Google Ventures since its inception. Prior to Google he helped start an electronic data interchange company that was acquired by Hewlett-Packard and a network security company that was acquired by Symantec. He also co-authored the business plan for Diagnostics For All, which won both the Harvard Business School and MIT $100k business plan competitions.
Previously, Krishna published several book chapters and journal articles in the field of computer-guided surgery, completed research in tissue engineering, and developed and licensed multiple surgical devices. He has worked with the technology transfer offices of MIT, Harvard, and Massachusetts General Hospital.